Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Gerretsen

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Psychiatry|January 14, 2017
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With SchizophreniaYusuke Iwata, Shinichiro Nakajima, Fernando Caravaggio, et al.
Neuropsychology|August 4, 2022
Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performanceMelissa Milanovic, Chelsea Wood-Ross, Meryl A Butters, et al.
Psychopharmacology|August 26, 2016
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy studyGagan Fervaha, Fernando Caravaggio, David C Mamo, et al.
Neuroscience and Biobehavioral Reviews|October 31, 2021
Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysisFumihiko Ueno, Yusuke Iwata, Shinichiro Nakajima, et al.
Neuroimage. Clinical|October 12, 2021
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophreniaTakashi Itahashi, Yoshihiro Noda, Yusuke Iwata, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 5, 2019
Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive ImpairmentEric E Brown, Neda Rashidi-Ranjbar, Fernando Caravaggio, et al.
Schizophrenia Research|June 23, 2024
Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy studyEdgardo Torres-Carmona, Shinichiro Nakajima, Yusuke Iwata, et al.
Psychiatry Research|July 19, 2022
Epigenetic age dysregulation in individuals with bipolar disorder and schizophreniaRichie Jeremian, Alexandra Malinowski, Zanib Chaudhary, et al.
Psychiatry and Clinical Neurosciences|September 16, 2022
Gamma-aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment-resistant schizophrenia: A proton magnetic resonance spectroscopy (<sup>1</sup> H-MRS) studyFumihiko Ueno, Shinichiro Nakajima, Yusuke Iwata, et al.
Frontiers in Neurology|April 8, 2026
Neural correlates of illness awareness in obesity: an exploratory pilot fMRI studyJianmeng Song, Julia Kim, Danielle Bukovsky, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Psychiatry|January 14, 2017
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With SchizophreniaYusuke Iwata, Shinichiro Nakajima, Fernando Caravaggio, et al.
Neuropsychology|August 4, 2022
Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performanceMelissa Milanovic, Chelsea Wood-Ross, Meryl A Butters, et al.
Psychopharmacology|August 26, 2016
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy studyGagan Fervaha, Fernando Caravaggio, David C Mamo, et al.
Neuroscience and Biobehavioral Reviews|October 31, 2021
Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysisFumihiko Ueno, Yusuke Iwata, Shinichiro Nakajima, et al.
Neuroimage. Clinical|October 12, 2021
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophreniaTakashi Itahashi, Yoshihiro Noda, Yusuke Iwata, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 5, 2019
Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive ImpairmentEric E Brown, Neda Rashidi-Ranjbar, Fernando Caravaggio, et al.
Schizophrenia Research|June 23, 2024
Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy studyEdgardo Torres-Carmona, Shinichiro Nakajima, Yusuke Iwata, et al.
Psychiatry Research|July 19, 2022
Epigenetic age dysregulation in individuals with bipolar disorder and schizophreniaRichie Jeremian, Alexandra Malinowski, Zanib Chaudhary, et al.
Psychiatry and Clinical Neurosciences|September 16, 2022
Gamma-aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment-resistant schizophrenia: A proton magnetic resonance spectroscopy (<sup>1</sup> H-MRS) studyFumihiko Ueno, Shinichiro Nakajima, Yusuke Iwata, et al.
Frontiers in Neurology|April 8, 2026
Neural correlates of illness awareness in obesity: an exploratory pilot fMRI studyJianmeng Song, Julia Kim, Danielle Bukovsky, et al.
Pageof 20